
RNXT
Healthcare · Biotechnology · $50.2M market cap
$1.04-0.12 (-10.3%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · 0.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | After the close | -0.05 | -0.07 | -40.0% |
| Aug 12, 2026 | After the close | -0.08 | -0.05 | +37.5% |
| May 14, 2026 | After the close | -0.08 | -0.08 | 0.0% |
| Nov 13, 2025 | After the close | -0.08 | -0.08 | 0.0% |
| Aug 14, 2025 | After the close | -0.08 | -0.08 | 0.0% |
| May 15, 2025 | After the close | -0.08 | -0.08 | 0.0% |
| Nov 13, 2024 | After the close | -0.12 | -0.10 | +16.7% |
| Aug 13, 2024 | After the close | -0.11 | -0.10 | +9.1% |
| Apr 1, 2024 | After the close | -0.30 | -0.30 | 0.0% |
| Mar 19, 2024 | After the close | -0.30 | -0.31 | -3.3% |
| Nov 13, 2023 | After the close | -0.28 | -0.13 | +53.6% |
| Aug 16, 2023 | After the close | -0.29 | -0.22 | +24.1% |
| May 12, 2023 | After the close | -0.25 | -0.36 |
RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. The company was founded in 2009 and is…
| -44.0% |
| Mar 2, 2023 | Before the open | -0.26 | -0.23 | +11.5% |
| Nov 14, 2022 | Before the open | -0.29 | -0.24 | +17.2% |
| Aug 12, 2022 | After the close | -0.28 | -0.29 | -3.6% |
| May 13, 2022 | After the close | -0.21 | -0.33 | -57.1% |
| Mar 30, 2022 | Before the open | -0.16 | -0.12 | +25.0% |
| Nov 15, 2021 | After the close | -0.21 | -0.27 | -28.6% |
| Aug 27, 2021 | Before the open | -0.58 | -0.48 | +17.2% |
| Jun 30, 2021 | Time not confirmed | 0.00 | -0.57 | — |
| Mar 31, 2021 | Time not confirmed | 0.00 | -0.51 | — |
| Jun 30, 2020 | Time not confirmed | 0.00 | -0.35 | — |
| Mar 31, 2020 | Time not confirmed | 0.00 | -0.48 | — |